Jo Ann Davis

Does Aggressive Surgery Only Benefit Patients With Less Advanced Ovarian Cancer? Results From an International Comparison Within the SCOTROC-1 Trial

Simon C. Crawford, P. Vasey, A. Hay et al. · Journal of Clinical Oncology · 2005 · 199 citations · Full text

Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer

Stan B. Kaye, Craig Lewis, James Paul et al. · The Lancet · 1992 · 161 citations

Epithelial Ovarian Cancer, Medicine, Pharmacology +6

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.

S.B. Kaye, James Paul, J Cassidy et al. · Journal of Clinical Oncology · 1996 · 139 citations

Docetaxel and Cisplatin in Combination as First-Line Chemotherapy for Advanced Epithelial Ovarian Cancer

P. Vasey, James Paul, A. Birt et al. · Journal of Clinical Oncology · 1999 · 72 citations

Estrogen and progesterone receptors in ovarian cancer

M. Harding, S. Cowan, D. Hole et al. · Cancer · 1990 · 70 citations